Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Judith Anzures-Cabrera
36  Ergebnisse:
Personensuche X
?
1

Identifying prodromal symptoms at high specificity for Park..:

Jackson, Holly ; Anzures-Cabrera, Judith ; Simuni, Tanya...
Frontiers in Aging Neuroscience.  15 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Phase Ib Study Design Evaluating The Safety, Pharmacokineti..:

D'Urso, Giulia ; Thomann, Alessandra ; Anzures-Cabrera, Judith...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
3

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Pagano, Gennaro ; Boess, Frank G. ; Taylor, Kirsten I....
Frontiers in Neurology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
4

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Pred..:

Jackson, Holly ; Anzures-Cabrera, Judith ; Taylor, Kirsten I....
Frontiers in Neuroscience.  15 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
5

Efficacy and safety of lebrikizumab in adult patients with ..:

Korenblat, Philip ; Kerwin, Edwin ; Leshchenko, Igor...
Respiratory Medicine.  134 (2018)  - p. 143-149 , 2018
Link: https://doi.org/10.1016/..
 
?
6

The effect of cholesteryl ester transfer protein inhibition..:

Ray, Kausik K. ; Ditmarsch, Marc ; Kallend, David...
European Heart Journal.  35 (2014)  27 - p. 1792-1800 , 2014
Link: https://doi.org/10.1093/..
 
?
7

Effect of Hepatic and Renal Impairment on the Pharmacokinet..:

Phelan, Mary ; Anzures-Cabrera, Judith ; Carlile, David J....
Clinical Pharmacokinetics.  52 (2013)  4 - p. 255-265 , 2013
Link: https://doi.org/10.1007/..
 
?
8

In vivo evaluation of drug-drug interactions linked to UGT ..:

Baldó, Pau Aceves ; Anzures-Cabrera, Judith ; Bentley, Darren
Int. Journal of Clinical Pharmacology and Therapeutics.  51 (2013)  3 - p. 215-218 , 2013
Link: https://doi.org/10.5414/..
 
?
9

No clinically relevant drug–drug interactions when dalcetra..:

Young, Annie ; Anzures-Cabrera, Judith ; Derks, Michael
Int. Journal of Clinical Pharmacology and Therapeutics.  50 (2012)  4 - p. 248-256 , 2012
Link: https://doi.org/10.5414/..
 
?
10

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Fo..:

Derks, Michael ; Anzures-Cabrera, Judith ; Turnbull, Lynn.
Clinical Drug Investigation.  31 (2011)  5 - p. 325-335 , 2011
Link: https://doi.org/10.1007/..
 
?
11

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Fo..:

Derks, Michael ; Anzures-Cabrera, Judith ; Turnbull, Lynn.
Clinical Drug Investigation.  , 2011
Link: https://doi.org/10.2165/..
 
?
12

Effect of Hepatic Impairment on the Pharmacokinetics of Dal..:

Phelan, Mary ; Kuhlmann, Olaf ; Anzures-Cabrera, Judith..
Journal of Clinical Lipidology.  4 (2010)  3 - p. 215-216 , 2010
Link: https://doi.org/10.1016/..
 
?
13

No Clinically Relevant Drug-Drug Interactions Between Dalce..:

Young, Anne-Marie ; Foley-Comer, Adam ; Anzures-Cabrera, Judith.
Journal of Clinical Lipidology.  4 (2010)  3 - p. 216 , 2010
Link: https://doi.org/10.1016/..
 
?
14

Data_Sheet_1_Identifying prodromal symptoms at high specifi..:

Holly Jackson ; Judith Anzures-Cabrera ; Tanya Simuni...
doi:10.3389/fnagi.2023.1232387.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Identifying prodromal symptoms at high specificity for Park..:

Holly Jackson ; Judith Anzures-Cabrera ; Tanya Simuni...
https://www.frontiersin.org/articles/10.3389/fnagi.2023.1232387/full.  , 2023
Link: https://doi.org/10.3389/..
 
1-15